{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T18:10:17Z","timestamp":1785175817223,"version":"3.55.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"vor","delay-in-days":303,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["-26\/102.173\/2013"],"award-info":[{"award-number":["-26\/102.173\/2013"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["-26\/102.125\/2011"],"award-info":[{"award-number":["-26\/102.125\/2011"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["-26\/0.010.002169\/2015"],"award-info":[{"award-number":["-26\/0.010.002169\/2015"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010435","name":"Universidade Federal Fluminense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010435","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.imlet.2020.09.002","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T11:28:52Z","timestamp":1600169332000},"page":"15-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Successful DAA therapy for chronic hepatitis C reduces HLA-DR on monocytes and circulating immune mediators: A long-term follow-up study"],"prefix":"10.1016","volume":"228","author":[{"given":"Natalia Fonseca","family":"Ros\u00e1rio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge\u00f3rgia do Nascimento","family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thalia","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Gandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilmar","family":"Lacerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Em\u00edlio Corr\u00eaa","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tha\u00eds Guaran\u00e1","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elzinandes Leal","family":"Azeredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anal\u00facia Rampazzo","family":"Xavier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Alice","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2020.09.002_bib0005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.coi.2016.06.009","article-title":"Innate immunity against hepatitis C virus","volume":"42","author":"Xu","year":"2016","journal-title":"Curr. Opin. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2020.09.002_bib0010","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cld.2008.03.003","article-title":"Hepatitis C and innate immunity: recent advances","volume":"12","author":"Szabo","year":"2008","journal-title":"Clin. Liver Dis."},{"issue":"6","key":"10.1016\/j.imlet.2020.09.002_bib0015","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2017.07.028","article-title":"Monocytes inhibit hepatitis C virus-induced TRAIL expression on CD56bright NK cells","volume":"67","author":"Mele","year":"2017","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.imlet.2020.09.002_bib0020","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/hep.21938","article-title":"Altered innate immunity in chronic hepatitis C infection: cause or effect?","volume":"46","author":"Szabo","year":"2007","journal-title":"Hepatol. Baltim. Md."},{"issue":"10","key":"10.1016\/j.imlet.2020.09.002_bib0025","first-page":"17995","article-title":"Expression profile and kinetics of cytokines and chemokines in patients with chronic hepatitis C","volume":"8","author":"Han","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.imlet.2020.09.002_bib0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.antiviral.2017.02.001","article-title":"Strategies for serum chemokine\/cytokine assessment as biomarkers of therapeutic response in HCV patients as a prototype to monitor immunotherapy of infectious diseases","volume":"141","author":"Menezes","year":"2017","journal-title":"Antiviral Res."},{"issue":"12","key":"10.1016\/j.imlet.2020.09.002_bib0035","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1093\/infdis\/jiw457","article-title":"Direct-acting antiviral-induced hepatitis C virus clearance does not completely restore the altered cytokine and chemokine milieu in patients with chronic hepatitis C","volume":"214","author":"Hengst","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.imlet.2020.09.002_bib0040","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.3390\/ijms15034747","article-title":"The role of chemokines in hepatitis C virus-mediated liver disease","volume":"15","author":"Brass","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.imlet.2020.09.002_bib0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/cmi.2013.37","article-title":"The role of chemokines in acute and chronic hepatitis C infection","volume":"11","author":"Fahey","year":"2014","journal-title":"Cell. Mol. Immunol."},{"issue":"16","key":"10.1016\/j.imlet.2020.09.002_bib0050","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","article-title":"Nomenclature of monocytes and dendritic cells in blood","volume":"116","author":"Ziegler-Heitbrock","year":"2010","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.imlet.2020.09.002_bib0055","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1084\/jem.20170355","article-title":"The fate and lifespan of human monocyte subsets in steady state and systemic inflammation","volume":"214","author":"Patel","year":"2017","journal-title":"J. Exp. Med."},{"issue":"5966","key":"10.1016\/j.imlet.2020.09.002_bib0060","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1126\/science.1178331","article-title":"Development of monocytes, macrophages, and dendritic cells","volume":"327","author":"Geissmann","year":"2010","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.imlet.2020.09.002_bib0065","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1182\/blood-2010-12-326355","article-title":"Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets","volume":"118","author":"Wong","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.imlet.2020.09.002_bib0070","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/cmi.2013.70","article-title":"An unbalanced PD-L1\/CD86 ratio in CD14(++)CD16(+) monocytes is correlated with HCV viremia during chronic HCV infection","volume":"11","author":"Zheng","year":"2014","journal-title":"Cell. Mol. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2020.09.002_bib0075","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00134-010-2099-7","article-title":"Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis","volume":"37","author":"Berry","year":"2011","journal-title":"Intensive Care Med."},{"issue":"6","key":"10.1016\/j.imlet.2020.09.002_bib0080","doi-asserted-by":"crossref","first-page":"e0157771","DOI":"10.1371\/journal.pone.0157771","article-title":"Altered peripheral blood monocyte phenotype and function in chronic liver disease: implications for hepatic recruitment and systemic inflammation","volume":"11","author":"Gadd","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.imlet.2020.09.002_bib0085","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1161\/CIRCGENETICS.111.960385","article-title":"Elevated CD14++CD16- monocytes predict cardiovascular events","volume":"5","author":"Berg","year":"2012","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.imlet.2020.09.002_bib0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fphys.2012.00056","article-title":"Functional role of monocytes and macrophages for the inflammatory response in acute liver injury","volume":"3","author":"Zimmermann","year":"2012","journal-title":"Front. Physiol."},{"issue":"3","key":"10.1016\/j.imlet.2020.09.002_bib0095","doi-asserted-by":"crossref","first-page":"e17484","DOI":"10.1371\/journal.pone.0017484","article-title":"Hyper-activated pro-inflammatory CD16 monocytes correlate with the severity of liver injury and fibrosis in patients with chronic hepatitis B","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.imlet.2020.09.002_bib0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/hep.27890","article-title":"Safety and tolerability of ledipasvir\/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: analysis of phase III ION trials","volume":"62","author":"Alqahtani","year":"2015","journal-title":"Hepatol. Baltim. Md."},{"issue":"1","key":"10.1016\/j.imlet.2020.09.002_bib0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.27826","article-title":"Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: an integrated safety and efficacy analysis","volume":"62","author":"Reddy","year":"2015","journal-title":"Hepatol. Baltim. Md."},{"key":"10.1016\/j.imlet.2020.09.002_bib0110","series-title":"Brazil. M of H. Clinical Protocol and Therapeutic Guidance for Hepatitis C and Coinfections","year":"2017"},{"issue":"2","key":"10.1016\/j.imlet.2020.09.002_bib0115","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s10620-017-4749-x","article-title":"Direct-acting antiviral therapy for chronic HCV infection results in liver stiffness regression over 12 months post-treatment","volume":"63","author":"Chan","year":"2018","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.imlet.2020.09.002_bib0120","doi-asserted-by":"crossref","first-page":"8578051","DOI":"10.1155\/2018\/8578051","article-title":"Restoring inflammatory mediator balance after sofosbuvir-induced viral clearance in patients with chronic hepatitis C","volume":"2018","author":"Saraiva","year":"2018","journal-title":"Mediators Inflamm."},{"issue":"1","key":"10.1016\/j.imlet.2020.09.002_bib0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12951-016-0238-1","article-title":"Poly-lactic acid nanoparticles (PLA-NP) promote physiological modifications in lung epithelial cells and are internalized by clathrin-coated pits and lipid rafts","volume":"15","author":"da Luz","year":"2017","journal-title":"J. Nanobiotechnology"},{"issue":"3","key":"10.1016\/j.imlet.2020.09.002_bib0130","first-page":"291","article-title":"Early changes in dynamic biomarkers of liver fibrosis in hepatitis C virus-infected patients treated with sofosbuvir","volume":"48","author":"Bernuth","year":"2016","journal-title":"Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver"},{"issue":"6","key":"10.1016\/j.imlet.2020.09.002_bib0135","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s11096-017-0552-1","article-title":"Adverse effects of direct acting antiviral-based regimens in chronic hepatitis C patients: a Brazilian experience","volume":"39","author":"Medeiros","year":"2017","journal-title":"Int. J. Clin. Pharm."},{"issue":"1","key":"10.1016\/j.imlet.2020.09.002_bib0140","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.gastro.2004.10.005","article-title":"Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats","volume":"128","author":"Imamura","year":"2005","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.imlet.2020.09.002_bib0145","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.2353\/ajpath.2009.080632","article-title":"Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice","volume":"174","author":"Mitchell","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.imlet.2020.09.002_bib0150","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","article-title":"Targeting hepatic macrophages to treat liver diseases","volume":"66","author":"Tacke","year":"2017","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.imlet.2020.09.002_bib0155","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/hep.26016","article-title":"Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics","volume":"57","author":"Liaskou","year":"2013","journal-title":"Hepatol. Baltim. Md."},{"issue":"6","key":"10.1016\/j.imlet.2020.09.002_bib0160","doi-asserted-by":"crossref","first-page":"e11049","DOI":"10.1371\/journal.pone.0011049","article-title":"Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis","volume":"5","author":"Zimmermann","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2020.09.002_bib0165","doi-asserted-by":"crossref","first-page":"3612403","DOI":"10.1155\/2017\/3612403","article-title":"Dynamic changes of the frequency of classic and inflammatory monocytes subsets and natural killer cells in chronic hepatitis C patients treated by direct-acting antiviral agents","volume":"2017","author":"Ning","year":"2017","journal-title":"Can. J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.imlet.2020.09.002_bib0170","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1510\/icvts.2007.158899","article-title":"Delayed recovery of human leukocyte antigen-DR expression after cardiac surgery with early non-lethal postoperative complications: only an epiphenomenon?","volume":"7","author":"Franke","year":"2008","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"issue":"2","key":"10.1016\/j.imlet.2020.09.002_bib0175","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/bjs.1800770225","article-title":"Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient","volume":"77","author":"Hershman","year":"1990","journal-title":"Br. J. Surg."},{"issue":"8","key":"10.1016\/j.imlet.2020.09.002_bib0180","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1097\/01.CCM.0000275271.77350.B6","article-title":"Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: correlation with severity and secondary septic shock","volume":"35","author":"Venet","year":"2007","journal-title":"Crit. Care Med."},{"issue":"12","key":"10.1016\/j.imlet.2020.09.002_bib0185","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1097\/00003246-199512000-00006","article-title":"Immunodepression following neurosurgical procedures","volume":"23","author":"Asadullah","year":"1995","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.imlet.2020.09.002_bib0190","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.3389\/fimmu.2019.01926","article-title":"Direct-acting antiviral treatment of HCV infection does not resolve the dysfunction of circulating CD8+ T-Cells in advanced liver disease","volume":"10","author":"Vranjkovic","year":"2019","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.imlet.2020.09.002_bib0195","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20022156","article-title":"Fractalkine preferentially mediates arrest and migration of CD16+ monocytes","volume":"197","author":"Ancuta","year":"2003","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.imlet.2020.09.002_bib0200","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1074-7613(03)00174-2","article-title":"Blood monocytes consist of two principal subsets with distinct migratory properties","volume":"19","author":"Geissmann","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2020.09.002_bib0205","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cyto.2017.04.008","article-title":"Cytokine profile in chronic hepatitis C: an observation","volume":"96","author":"Baskic","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.imlet.2020.09.002_bib0210","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cyto.2018.10.004","article-title":"Quantitative analysis of serum chemokines associated with treatment failure of direct-acting antivirals in chronic hepatitis C","volume":"111","author":"Umemura","year":"2018","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.imlet.2020.09.002_bib0215","first-page":"61","article-title":"Th17 and IL-17 as Predictors of Hepatic Inflammation in Patients with Chronic Hepatitis C Virus Infection and Treated With Direct Antiviral Therapy","volume":"25","author":"Abou El-Khier","year":"2018","journal-title":"Egypt. J. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2020.09.002_bib0220","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"Meng","year":"2012","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.imlet.2020.09.002_bib0225","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.4049\/jimmunol.1203013","article-title":"IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation","volume":"191","author":"Tan","year":"1950","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.imlet.2020.09.002_bib0230","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.4049\/jimmunol.1200385","article-title":"IL-17 and TNF-\u03b1 sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation","volume":"188","author":"Griffin","year":"2012","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2020.09.002_bib0235","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1159\/000430197","article-title":"Interleukin-17 stimulates STAT3-Mediated endothelial cell activation for neutrophil recruitment","volume":"36","author":"Yuan","year":"2015","journal-title":"Cell Physiol. Biochem. Int. J. Exp. Cell Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.imlet.2020.09.002_bib0240","doi-asserted-by":"crossref","first-page":"4738237","DOI":"10.1155\/2019\/4738237","article-title":"Immunological dynamics associated with direct-acting antiviral therapies in naive and experimented HCV chronic-infected patients","volume":"2019","author":"Pereira","year":"2019","journal-title":"Mediators Inflamm."},{"issue":"6","key":"10.1016\/j.imlet.2020.09.002_bib0245","doi-asserted-by":"crossref","first-page":"e21381","DOI":"10.1371\/journal.pone.0021381","article-title":"Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis","volume":"6","author":"Zimmermann","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.imlet.2020.09.002_bib0250","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The many roles of chemokines and chemokine receptors in inflammation","volume":"354","author":"Charo","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.imlet.2020.09.002_bib0255","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/jgh.12462","article-title":"Positioning of leukocyte subsets in the portal and lobular compartments of hepatitis C virus-infected liver correlates with local chemokine expression","volume":"29","author":"Nguyen","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.imlet.2020.09.002_bib0260","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1111\/j.1572-0241.2002.07054.x","article-title":"Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease","volume":"97","author":"Apolinario","year":"2002","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.imlet.2020.09.002_bib0265","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1189\/jlb.0303093","article-title":"Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation","volume":"74","author":"Harvey","year":"2003","journal-title":"J. Leukoc. Biol."},{"issue":"4","key":"10.1016\/j.imlet.2020.09.002_bib0270","doi-asserted-by":"crossref","first-page":"506","DOI":"10.5009\/gnl.2011.5.4.506","article-title":"Serum IP-10 levels correlate with the severity of liver histopathology in patients infected with Genotype-1 HCV","volume":"5","author":"You","year":"2011","journal-title":"Gut Liver"},{"issue":"10","key":"10.1016\/j.imlet.2020.09.002_bib0275","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2893.2006.00838.x","article-title":"The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection","volume":"14","author":"Zeremski","year":"2007","journal-title":"J. Viral Hepat."},{"issue":"47","key":"10.1016\/j.imlet.2020.09.002_bib0280","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.3748\/wjg.14.7149","article-title":"Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection","volume":"14","author":"Larrubia","year":"2008","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.imlet.2020.09.002_bib0285","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1038\/cti.2015.39","article-title":"Differentiation of human monocytes and derived subsets of macrophages and dendritic cells by the HLDA10 monoclonal antibody panel","volume":"5","author":"Ohradanova-Repic","year":"2016","journal-title":"Clin. Transl. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2020.09.002_bib0290","doi-asserted-by":"crossref","first-page":"e0176460","DOI":"10.1371\/journal.pone.0176460","article-title":"Phenotype, function, and differentiation potential of human monocyte subsets","volume":"12","author":"Boyette","year":"2017","journal-title":"PLoS One"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247820303813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247820303813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:46:23Z","timestamp":1777495583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247820303813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":58,"alternative-id":["S0165247820303813"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2020.09.002","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful DAA therapy for chronic hepatitis C reduces HLA-DR on monocytes and circulating immune mediators: A long-term follow-up study","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2020.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Federation of Immunological Societies. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}